Vascular Affection in Behcet Disease
NCT06280430 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2024-02-28
Summary
To measure the level of serum elafin in patients with behcet disease and to assess the correlation between serum elafin and vascular affection and their relation with disease activity
Conditions
- Behcet Disease and Vascular Involvement
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2025-03-01
- Completion
- 2025-04-01
More Related Trials
-
Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis
NCT05565885 ·Status: RECRUITING
-
How Sirtuin Levels Change During Behçet Disease
NCT06266247 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital
NCT06601361 ·Status: NOT_YET_RECRUITING
-
CRP /albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients
NCT06750315 ·Status: NOT_YET_RECRUITING
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 ·Status: RECRUITING
-
Mucocutaneous Manifestations in Patients With Chronic Kidney Disease inNewVally and Assuit;Hospital Based Study
NCT05819320 ·Status: NOT_YET_RECRUITING
-
Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)
NCT04959435 ·Status: COMPLETED
-
Circulating Anti-Beta2-glycoprotein Antibodies and Endothelial Dysfunction
NCT01822990 ·Status: COMPLETED
-
Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease
NCT05868538 ·Status: COMPLETED
-
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
NCT07062523 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Renal Manifestations of IBD
NCT04301297 ·Status: UNKNOWN
-
A Study on Factors of Biochemical Response in Autoimmune Hepatitis
NCT06356506 ·Status: NOT_YET_RECRUITING
-
Development and Characterization of Functional Assays for the Analysis of Inflammation Signaling Pathways
NCT06971289 ·Status: NOT_YET_RECRUITING
-
Predictors of Spontaneous Bacterial Peritonitis Among Patients with Cirrhosis
NCT06884306 ·Status: NOT_YET_RECRUITING
-
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
NCT01063309 ·Status: COMPLETED
-
YKL -40 as New Biomarker in COVID -19 Patients
NCT05137509 ·Status: UNKNOWN
-
Immunogenetic Mechanisms in Behcet's Disease
NCT01109433 ·Status: TERMINATED
-
Patterns and Outcome of Autoimmune Related Liver Disease
NCT03898414 ·Status: COMPLETED
-
Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
NCT00517101 ·Status: UNKNOWN
-
Frequency and Risk Factors for Autoimmune Disorders and Rheumatic Manifestations in Egyptian Patients With IBD
NCT05771363 ·Status: UNKNOWN
-
Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients
NCT07003451 ·Status: NOT_YET_RECRUITING
-
Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases
NCT05670301 ·Status: RECRUITING ·Phase: NA
-
Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis
NCT00560989 ·Status: COMPLETED